Delivery Order SPE2DB22D3009-SPE2DB25FBA88
Award Date 7/14/25
Potential Completion Date 7/15/25
Potential Value $5.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,622.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for Omnipaque 300 mg/ml infusion bottles (100ml units). The contract, which is non-set-aside and competitively awarded, is scheduled for completion by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,282.49 to AmerisourceBergen Drug Corp for the supply of Omnipaque 300 mg/mL in 100 mL infusion bottles. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with performance based in Conshohocken, Pennsylvania, and an ultimate completion date of September 10, 2025. This delivery order represents a task issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $7,504.83 to AmerisourceBergen Drug Corp for the supply of Omnipaque 300 mg/mL infusion bottles (100 mL units). This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 24, 2025. AmerisourceBergen Drug Corp will perform the delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action...
- The Defense Logistics Agency awarded a delivery order valued at $1,171.00 to AmerisourceBergen Drug Corp for the supply of Omnipaque 300 mg/ml infusion bottles (100 ml units). The contract, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a firm fixed price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,997.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Omnipaque 300 mg/ml contrast medium in 100ml infusion bottles. The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive set-aside delivery order for medical imaging supplies. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal healthcare systems,...
- The Defense Logistics Agency awarded a $1,044.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Omnipaque 240 mg/ml vials (10 ml) on August 7, 2025, with an ultimate completion date of August 8, 2025. This delivery order is classified as non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value transaction typical of the company's extensive portfolio of pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order valued at $4,077.60 to AmerisourceBergen Drug Corp for the supply of Omnipaque 300 mg/mL infusion bottles (100 mL units). This firm fixed-price delivery order, issued on September 18, 2025, with completion targeted for September 19, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Omnipaque is a contrast medium commonly used in...
- The Defense Logistics Agency awarded a $1,673.00 delivery order to AmerisourceBergen Drug Corp for OMNIPAQUE 350 mg/mL infusion bottles (150 mL) on July 24, 2025, with completion scheduled for July 25, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order for pharmaceutical supplies to be performed at the awardee's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $1,200 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of OMNIPAQUE 240 mg/ml vials in 10 ml quantities. This is a firm fixed price, non-set-aside contract with a completion date of July 30, 2025, and performance location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), a $999.999 billion agreement...
- The Defense Logistics Agency awarded a delivery order valued at $3,381.60 to AmerisourceBergen Drug Corp for the supply of Omnipaque 350 mg/ml, a contrast media pharmaceutical product in 500ml Pluspak packaging. This firm fixed-price delivery order, awarded on July 24, 2025, represents a non-competitive, non-set-aside procurement with an ultimate completion date of July 25, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...